Kiora Pharmaceuticals (KPRX) Misses Q3 EPS by 81c

Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q3 EPS of ($0.81).

For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.

You May Also Be Interested In

• Anthropic agrees to $45bn cloud computing deal with Nscale - report
• BTIG Reiterates Buy Rating on Ship Finance International (SFL)
• Salesforce earnings preview: Analysts eye catalysts for stock upside